Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

I expect the reverse split and up-listing announcement will happen before the end of the month.

Common sense says to do it as soon as possible. If the catalyst are there then there's no logical reason to delay doing so.

If Gerald actually intends to spin-off the diagnostics division as a new company doesn't it make more sense to do so with AMBS already trading on the NASDAQ and have the new company begin trading on the NASDAQ than to have two penny stock companies trading on the O.T.C. with each of them facing a reverse split to up-list?

Interesting weeks ahead.